Zobrazeno 1 - 10
of 224
pro vyhledávání: '"E. P. Panchenko"'
Autor:
O. O. Shakhmatova, A. L. Komarov, U. P. Ergasheva, V. V. Korobkova, L. O. Minushkina, V. A. Brazhnik, D. A. Zateyshchikov, E. B. Yarovaya, E. P. Panchenko
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 4 (2024)
Aim. To evaluate and compare the prognostic value of various scales on the risk of upper gastrointestinal bleeding (GIB) in patients with stable coronary artery disease (CAD) in the Russian population.Material and methods. The study included patients
Externí odkaz:
https://doaj.org/article/808641074deb4cc899ba2e5198914136
Autor:
M. B. Khakimova, A. L. Komarov, A. B. Dobrovolsky, E. V. Titaeva, V. V. Kadochnikova, D. D. Abramov, E. P. Panchenko
Publikováno v:
Атеротромбоз, Vol 13, Iss 2, Pp 16-27 (2024)
Introduction. Patients undergoing elective myocardial revascularization require 6 months of dual antiplatelet therapy (DAPT), including aspirin and clopidogrel. In patients with multifocal atherosclerotic lesion (MFA), it may be reasonable to extend
Externí odkaz:
https://doaj.org/article/4032d57357514dc6b0b82b1140824a58
Publikováno v:
Атеротромбоз, Vol 13, Iss 1, Pp 46-57 (2023)
Introduction. Lengthening the period of direct oral anticoagulant (DOAC) withdrawal before intervention is not allowed. Chronic kidney disease (CKD), impaired liver function, extremely low or high body mass, chronic heart failure (CHF), and age > 90
Externí odkaz:
https://doaj.org/article/03e97d69c95149df81b09922849727b6
Autor:
E. S. Kropacheva, E. P. Panchenko
Publikováno v:
Атеротромбоз, Vol 13, Iss 1, Pp 36-45 (2023)
This review is devoted to the aspects of anticoagulant therapy in patients with atrial fibrillation in the light of the modern understanding of this type of arrhythmia as a polymorbid continuously developing syndrome. According to experts, the manage
Externí odkaz:
https://doaj.org/article/5d6ee33ff4f34e448ac0343d721b9875
Autor:
M. B. Khakimova, A. L. Komarov, E. N. Krivosheeva, V. M. Mironov, S. K. Kurbanov, S. O. Kuzyakina, E. B. Yarovaya, E. P. Panchenko
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 22, Iss 9 (2023)
Aim. To identify factors determining the prognosis after elective myocardial revascularization in patients with coronary artery disease (CAD) with multifocal atherosclerosis (MFA).Material and methods. The study is based on the prospective registry R
Externí odkaz:
https://doaj.org/article/0346ca9eb63944f3a8d5f8107bf346bc
Autor:
Yu. A. Fedotkina, E. P. Panchenko
Publikováno v:
Атеротромбоз, Vol 12, Iss 2, Pp 44-62 (2023)
Cancer is one of the most significant risk factors for venous thromboembolic complications (VTEC), which combines deep vein thrombosis and pulmonary embolism. Of the many well-known risk factors for VTEC, only cancer is associated with a 4-fold incre
Externí odkaz:
https://doaj.org/article/c2b47f68a4d84a09b534e679071a2b10
Autor:
E. P. Panchenko
Publikováno v:
Атеротромбоз, Vol 12, Iss 2, Pp 32-42 (2023)
After the appearance of direct oral anticoagulants (DOAC), the use of vitamin K antagonists (VKA) has become more rare, but nevertheless, there are diseases in which they remain indispensable drugs. This review is devoted to VKA and the diseases in w
Externí odkaz:
https://doaj.org/article/41dd7f3f36bf418eb00faaac9ad6c586
Autor:
S. A. Boytsov, N. V. Pogosova, A. A. Ansheles, V. A. Badtieva, T. V. Balakhonova, O. L. Barbarash, Yu. A. Vasyuk, N. G. Gambaryan, G. E. Gendlin, S. P. Golitsyn, O. M. Drapkina, L. Yu. Drozdova, M. V. Yezhov, A. I. Ershova, I. V. Zhirov, Yu. A. Karpov, Zh. D. Kobalava, A. V. Kontsevaya, A. Yu. Litvin, M. M. Lukyanov, S. Yu. Martsevich, S. T. Matskeplishvili, V. A. Metelskaya, A. N. Meshkov, I. E. Mishina, E. P. Panchenko, A. B. Popova, I. V. Sergienko, M. D. Smirnova, M. I. Smirnova, O. Yu. Sokolova, A. V. Starodubova, O. Yu. Sukhareva, S. K. Ternovoy, O. N. Tkacheva, S. A. Shalnova, M. V. Shestakova
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 5 (2023)
Russian Society of Cardiology, National Society of Preventive Cardiology
Externí odkaz:
https://doaj.org/article/6af42f5729d84c1784d8c6fd021217b0
Autor:
E. P. Panchenko
Publikováno v:
Атеротромбоз, Vol 12, Iss 1, Pp 84-112 (2022)
The COVID-19 epidemic is accompanied by an increase in the frequency of rhythm disturbances and, in particular, atrial fibrillation. This article is a clinical analysis of a patient whose atrial fibrillation (fluttering) occurred due to an infection.
Externí odkaz:
https://doaj.org/article/1b245f03b90b47a3ad5318dbffcaf239
Publikováno v:
Атеротромбоз, Vol 12, Iss 1, Pp 20-28 (2022)
Currently, direct oral anticoagulants (DOACs) should be preferred when prescribing anticoagulant therapy to atrial fibrillation patients because of their lower potential for interactions and risk of bleeding than warfarin. However, in the absence of
Externí odkaz:
https://doaj.org/article/71611dab20b84396b106049e7821be96